Aminoglutethimide prevents excitotoxic and ischemic injuries in cortical neurons

British Journal of Pharmacology

Volumn 147, Issue 7, 2006, Pages 729-736

  Shirakawa, Hisashi ^a   Katsuki, Hiroshi ^a   Kume, Toshiaki ^a   Kaneko, Shuji ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cerebral cortex; Excitotoxicity; Ischemia; Neuroactive steroid; Neuronal death

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINOGLUTETHIMIDE; ESTRADIOL; ESTRIOL; ESTRONE; EXEMESTANE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOMYCIN; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROSTEROID; PREGNENOLONE; STAUROSPORINE; STEROID; TRILOSTANE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN SLICE; CALCIUM CELL LEVEL; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; EXCITOTOXICITY; FEMALE; FETUS; LONG TERM CARE; NERVE CELL CULTURE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STEROIDOGENESIS;

ADRENERGIC AGENTS; AMINOGLUTETHIMIDE; ANIMALS; BRAIN ISCHEMIA; CALCIUM; CELL DEATH; CEREBRAL CORTEX; FEMALE; GLUTAMIC ACID; L-LACTATE DEHYDROGENASE; NEURONS; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; RATS; STEROIDS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 33645534700     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706636     Document Type: Article

References (34)

1. ALSHOWAIER, I.A., EL-YAZIGI, A., EZZAT, A., ABDEL-WARITH, A. & NICOLLS, P.J. (1999). Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients. J. Clin. Pharmacol., 39, 1136-1142.
2. BASTIDA, C.M., TEJADA, F., CREMADES, A. & PANAFIEL, R. (2001). Aminoglutethimide, a steroidogenesis inhibitor, abolishes hormonal induction of ornithine decarboxylase in steroidogenic tissues: evidence for its role as cAMP-dependent protein kinase inhibitor. Biochem. Biophys. Res. Commun., 281, 244-248.
3. COIRINI, H., GOUEZOU, M., DELESPIERRE, B., LIERE, P., PIANOS, A., EYCHENNE, B., SCHUMACHER, M. & GUENNOUN, R. (2003). Characterization and regulation of the 3β-hydroxysteroid dehydrogenase isomerase enzyme in the rat sciatic nerve. J. Neurochem., 84, 119-126.
4. DI SALLE, E., BRIATICO, G., GIUDICI, D., ORNATI, G., ZACCHEO, T., BUZZETTI, F., NESI, M. & PANZERI, A. (1994). Novel aromatase and 5α-reductase inhibitors. J. Steroid Biochem. Mol. Biol., 49, 289-294.
5. FOSTER, A.B., JARMAN, M., LEUNG, C.S., ROWLANDS, M.G. & TAYLOR, G.N. (1983). Analogues of aminoglutethimide: selective inhibition of cholesterol side-chain cleavage. J. Med. Chem., 26, 50-54.
6. FUJIMOTO, S., KATSUKI, H., KUME, T., KANEKO, S. & AKAIKE, A. (2004). Mechanisms of oxygen glucose deprivation-induced glutamate release from cerebrocortical slice cultures. Neurosci. Res., 50, 179-187.
7. GUARNERI, P., RUSSO, D., CASCIO, C., DE LEO, G., PICCOLI, F. & GUARNERI, R. (1998). Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity. Eur. J. Neurosci., 10, 1752-1763.
8. HOLMES, G.L. (2002). Seizure-induced neuronal injury: animal data. Neurology, 59, S3-S6.
9. 2+ responses: structure-activity studies. J. Pharmacol. Exp. Ther., 271, 677-682.
10. KATSUKI, H., SHINOHARA, A., FUJIMOTO, S., KUME, T. & AKAIKE, A. (2005). Tetraethylammonium exacerbates ischemic neuronal injury in rat cerebrocortical slice cultures. Eur. J. Pharmacol., 508, 85-91.
11. KIMONIDES, V.G., KHATIBI, N.H., SVENDSEN, C.N., SOFRONIEW, M.V. & HERBERT, J. (1998). Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A., 95, 1852-1857.
12. KURATA, K., TAKEBAYASHI, M., MORINOBU, S. & YAMAWAKI, S. (2004). Estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms. J. Pharmacol. Exp. Ther., 311, 237-245.
13. MARAGAKIS, N.J. & ROTHSTEIN, J.D. (2004). Glutamate transporters: animal models to neurologic disease. Neurobiol. Dis., 15, 461-473.
14. MATTSON, M.P. (2003). Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med., 3, 65-94.
15. MELDRUM, B. & GARTHWAITE, J. (1990). Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci., 11, 379-387.
16. MELLON, S.H. & GRIFFIN, L.D. (2002). Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab., 13, 35-43.
17. MILLER, A.A., MILLER, B.E., HOFFKEN, K. & SCHMIDT, C.G. (1987). Clinical pharmacology of aminoglutethimide in patients with metastatic breast cancer. Cancer Chemother. Pharmacol., 20, 337-341.
18. MILLER, W.R., ANDERSON, T.J., EVANS, D.B., KRAUSE, A., HAMPTON, G. & DIXON, J.M. (2003). An integrated view of aromatase and its inhibition. J. Steroid Biochem. Mol. Biol., 86, 413-421.
19. NEDERGAARD, M., TAKANO, T. & HANSEN, A.J. (2002). Beyond the role of glutamate as a neurotransmitter. Nat. Rev. Neurosci., 3, 748-755.
20. NISHIZAWA, Y. (2001). Glutamate release and neuronal damage in ischemia. Life Sci., 69, 369-381.
21. PARK-CHUNG, M., WU, F.-S., PURDY, R.H., MALAYEV, A.A., GIBBS, T.T. & FARB, D.H. (1997). Distinct sites for inverse modulation of N-methyl-D-aspartate receptor by sulfated steroids. Mol. Pharmacol., 52, 1113-1123.
22. REDDY, D.S. (2003). Pharmacology of endogenous neuroactive steroids. Crit. Rev. Neurobiol., 15, 197-234.
23. ROBEL, P., YOUNG, J., CORPECHOT, C., MAYO, W., PERCHE, F., HAUG, M., SIMON, H. & BAULIEU, E.E. (1995). Biosynthesis and assay of neurosteroids in rats and mice: functional correlates. J. Steroid Biochem. Mol. Biol., 53, 355-360.
24. SALHANICK, H.A. (1982). Basic studies on aminoglutethimide. Cancer Res., 42, 3315s-3321s.
25. SHIRAKAWA, H., KATSUKI, H., KUME, T., KANEKO, S. & AKAIKE, A. (2005). Pregnenolone sulphate attenuates AMPA cytotoxicity on rat cortical neurons. Eur. J. Neurosci., 21, 2329-2335.
26. SHIRAKAWA, H., KATSUKI, H., KUME, T., KANEKO, S., ITO, J. & AKAIKE, A. (2002). Regulation of N-methyl-D-aspartate cytotoxicity by neuroactive steroids in rat cortical neurons. Eur. J. Pharmacol., 454, 165-175.
27. UNGER, C., EIBL, H., VON HEYDEN, H.W., KIM, D.J. & NAGEL, G.A. (1986). Aminoglutethimide. Penetration of the blood brain barrier. Invest. New Drugs, 4, 237-240.
28. VEIGA, S., GARCIA-SEGRA, L.M. & AZCOITIA, I. (2003). Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase. J. Neurobiol., 56, 398-406.
29. 2+ accumulation and cell death. J. Pharmacol. Exp. Ther., 293, 747-754.
30. WEAVER, C.E., MAREK, P., PARK-CHUNG, M., TAM, S.W. & FARB, D.H. (1997). Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A., 92, 10450-10454.
31. WEAVER JR, C.E., WU, F.S., GIBBS, T.T. & FARB, D.H. (1998). Pregnenolone sulfate exacerbates NMDA-induced death of hippocampal neurons. Brain Res., 803, 129-136.
32. WU, F.S., GIBBS, T.T. & FARB, D.H. (1991). Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol. Pharmacol., 40, 4333-4336.
33. YAGHOUBI, N., MALAYEV, A., RUSSEK, S.J., GIBBS, T.T. & FARB, D.H. (1998). Neurosteroid modulation of recombinant ionotropic glutamate receptors. Brain Res., 803, 153-160.
34. ZWAIN, I.H. & YEN, S.S. (1999). Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology, 140, 3843-3852.